开发,优化和评估用于治疗H.Pylori的阿莫西西林粘膜微球,通过全工厂设计
Bhawna Sharma1, Anand Chaurasia1, Naveen Gupta1
1Patel College of Pharmacy, Madhyanchal Professional University, Ratibad, Bhopal, MP. India.
概括
含有阿莫西西林的粘膜粘合微球被开发用于H. pylori治疗. 优化的配方显示出良好的粘膜粘附性,高药物捕获和持续释放,改善治疗结果.
科学领域:
- 制药科学 制药科学
- 药物输送系统 药物输送系统
- 微生物学 微生物学
背景情况:
- 氨基西林对于根除H. pylori至关重要,但需要有效的输送.
- 药物半衰期短,需要制定持续治疗水平的策略.
- 粘膜粘合系统在胃肠道中提供了长时间的停留时间.
研究的目的:
- 制定和评估含有阿莫西西林的粘膜粘合微球.
- 为了研究持续的药物释放以改善H. pylori治疗.
- 优化微球特性,以提高口服生物利用性.
主要方法:
- 使用乳化-交叉连接与瓜尔,酸和奇托制备的微球.
- 阿莫西西林被纳入了奇托溶液.
- 特性包括颗粒大小,粘膜粘合,药物捕获和体外释放研究.
主要成果:
- 微球颗粒大小在200-500微米之间.
- 优化的配方 (F-9) 显示了57.41%的粘膜粘合和94.87%的药物捕获.
- 在8小时内实现了68.52%的持续药物释放.
结论:
- 开发出的阿莫西西林微球在GIT中提供持续释放.
- 这种配方可以长时间保持稳定的血清药物度.
- 粘膜粘合微球为H.pylori治疗提供了一个有前途的方法.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
343
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
343
Peptic Ulcer Disease IV: Management
79
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
79


